Uptrend Under Pressure 100
Institutional selling is building — 7 distribution days in the last 25 sessions. Severe risk · 100/100 · 7 distribution days (SPY) Oct 26 Full briefing →
View
Simple research view

GILD · Gilead Sciences, Inc.

$158.69 +1.70% Oct 26 close
Detected setup Cup & Handle · Setup Score 70/100

Stand aside — setup invalidated

Setup score 70, but distribution days reach 5 or more — stand aside until the condition resets.

2 independent risk warnings also present. Review before relying on the bullish setup.

Ask about GILD

Switch to Advanced for indicator panels, raw grades, provenance, drawing tools, and full technical tables.

$GILD

Gilead Sciences, Inc.

Gilead Sciences, Inc. is a large-cap Biotechnology company in the Health Technology sector with a market cap of $197B.

Health Technology Biotechnology stock Stage 2 · Advancing Base 2
$158.69 latest close
Market Structure
Trend structure: uptrend
Latest event: structure_shift (bearish)
Support 127.07–129.02 · 12 touches · strong
Support 136.26–137.80 · 9 touches · strong
Support 142.60–143.18 · 6 touches · strong
Support 123.74–124.49 · 3 touches · moderate
Support 148.97–149.62 · 3 touches · moderate
Join to Watchlist $GILD Share card
Verdict · setup score 70/100 · data Oct 26 close · latest session

Stand aside — setup invalidated

Setup score 70, but distribution days reach 5 or more — stand aside until the condition resets.

Review six verdicts Inspect chart
Recent price action · daily
$140$160AugSepOct$159

What would change this verdict

What needs to turn for this to become buyable — the top failing checks across the legend council:

  • Minervini 1.2 150-day MA > 200-day MA — MA150 $137.99 vs MA200 $139.06
  • Minervini 2. Quarterly EPS growth ≥ 25% — -432.5% QoQ
  • O'Neil C: Quarterly EPS acceleration ≥ 25% — -432.5% QoQ
  • O'Neil A: Annual earnings & revenue quality — Rev +2.4% | ROE -16.3%
  • Weinstein Volume expansion above average — Volume ratio 1.05x
  • Weinstein Weekly price coiling (Stage 2 consolidation) — Tightening weekly range confirms base
Minority view — the council disagrees here
  • Minervini: avoid Trend-template read: fails 150-day MA > 200-day MA.
  • O'Neil: avoid CANSLIM read: fails C: Quarterly EPS acceleration ≥ 25%.
  • Weinstein: watch Stage-analysis read: Stage 2 is present; 2 supporting checks need improvement.
60 Neutral
Legend Score · rates the stock Neutral (60/100) — held back by eps growth

Our proprietary 0-100 rating — the answer to Wall Street's black-box scores. Five pillars, each computed from real scan data, each explained below in plain English.

  • Relative Strength (25%) 83
  • Trend Template (25%) 88
  • Institutional Footprint (20%) 38
  • EPS Growth (15%) 26
  • Quality (SMR-like) (15%) 38

RS rank 82: beating most of the market. Trend template 7/8: price above rising 50/150/200-day lines — textbook uptrend structure. Institutional score 38: mild distribution — sellers active. EPS -4% last quarter — no earnings momentum. Quality 38: weak fundamentals (sales growth 30, return on equity 40, leverage 60). Updated 2026-10-27.

Earnings

Pre-earnings setup

Next earnings Wednesday, October 28, 2026 Report time not confirmed by the source

Deterministic evidence

GILD+1.70%
Sector proxy · XLV+0.00%
Broad market · SPY+0.71%
Same completed session window ending 2026-10-26. GILD was +1.70 points vs XLV. +0.99 points vs SPY.
CatalystPending Stock reactionPositive Sector reactionWeak Opening surgePending Event riskEarnings-driven

Session internals Mixed

Rule: direction and internals disagree — it met neither the strong nor the weak rule. Judged on internals, not on the size of the move.

Vs prior close+1.70% From the open+0.68% Range position54% GapNo gap
QQQ confirmationConfirming (+1.11%) SMH confirmationConfirming (+2.74%)
Short-term conviction -1 points.
  • A sourced earnings report is still pending inside the risk window; ordinary technical conviction is reduced until it is out.
Price bars, sourced event fields, and benchmark math only. This can adjust displayed short-term conviction; it does not change the stored scanner score or readiness.

Ask a Legend to interpret this evidence → Commentary only — never scanner evidence or a sizing recommendation.

Price $158.69 +1.7% Oct 26 close
52W High $160.51 1.1% below high
Wks Since High 1w
Base Depth 5.5%
RS Rank 63 percentile of scan
SMA 50 $149.25
Avg Vol 5,778,803
Rel Vol (Oct 26) 1.05× 1.04× on up days
More stats
52W Low $114.02
Tight Wks 0
Base B2
SMA 200 $139.06
RS Line vs High -8.8%
RS Line Slope +4.7% ▲
Group Rank #9/65
ADR% 2.3%
ATR(14) $4.12 (2.6%)
Vol Pace (live) N/A
A/D Days 13A / 18D
A/D Rating E
VDU Bars 0/10 d
Power Trend 9d
Earnings tomorrow
Position in 52-week range 96thpercentile of the 52-week range
$114.02low
$160.51high

GILD Chart

Interactive price, volume, RS, RSI, and MACD charts are available after sign in.

Create a free account to load the full interactive chart for GILD.

Create Free Account

Technical Analysis Report Card

$GILD · $158.69 · as of 2026-10-26 · multi-factor read
100
/ 100
Technicals 100/100
Reference read from price & volume only — the verdict at the top of the page decides the action.

Trend · Daily / Weekly / Monthly

Daily ▲ Uptrend
Weekly ▲ Uptrend
Monthly ▲ Uptrend

Moving Averages

50-day$149.25 ↑
100-day$139.71 ↑
200-day$139.06 ↑
Bullish (50 > 200)

RSI (14)

Reading61.9 · Bullish

Bullish momentum — comfortably in buyer territory.

MACD (12/26/9)

StateBullish
Histogram+0.564

Bullish — MACD above its signal line and above zero. Histogram expanding.

Bollinger Bands (20,2)

%B / Width89% · 12.4%

Near the upper band — buyers in control.

Volume · Buyer vs Seller

Up/Down vol1.04 · Neutral
Rel volume1.05×
Pocket pivots · 10d0
5d vs 50d vol107%
Heavy vol up / down0 / 0

Balanced — up/down volume is roughly even; no clear hand. Recent volume is expanding versus its baseline.

Support & Resistance

R · $160.5152-week high
Price · $158.69now
S · $142.97swing level
S · $128.49swing level
S · $121.39swing level

Fibonacci · Uptrend swing

23.6%$151.28
38.2%$145.57
50.0%$140.95
61.8%$136.33
78.6%$129.76

Retracement support zones measured from the recent swing low up to the high.

The verdict is free. The trade plan is Pro.
Unlock the exact entry, stop-loss, profit target, and reward-to-risk for GILD — plus the full 500+ symbol scanner and Ask-the-Legends chat.
Start your 7-day free trial →
Daily uptrendWeekly uptrendMonthly uptrendAbove 200-day MA50/200 bullishRS 82 (leader)
Want this read in a legend's voice? Ask a Legend about GILD
Generic technical analysis generated mechanically from price & volume — educational research only, not financial advice or a personalized recommendation. Levels are illustrative; confirm on your own chart. New to these terms? →
Legend Verdicts 6 methodology checks

Who would consider this setup, why it qualifies, and what blocks it — calculated from the same deterministic methodology rules used across Legend AI.
How to read the numbers: the setup score (70/100, in the verdict band) rates this trade setup. Each legend's A–D grade rates the same setup against that legend's own checklist — so a high score next to a C grade is not a contradiction. The setup can be strong without fitting that legend's style. When the council disagrees, the verdict band breaks the tie.

Council consensus: 7 of 9 legends are Watching — building, not yet a confirmed buy.
Minervini Avoid C Trend-template read: fails 150-day MA > 200-day MA.

partialRule check says AVOID (8/13 checks passed) — Trend-template read: fails 150-day MA > 200-day MA.

Passing evidence
1.1 Price > 150-day MA AND 200-day MAPrice $158.69, MA150 $137.99, MA200 $139.06
1.4 50-day MA > 150-day MA AND 200-day MAMA50 $149.25, MA150 $137.99, MA200 $139.06
Failing evidence
1.2 150-day MA > 200-day MAMA150 $137.99 vs MA200 $139.06
2. Quarterly EPS growth ≥ 25%-432.5% QoQ
8/13 checks
Method → Playbook → Ask →
O'Neil Avoid D CANSLIM read: fails C: Quarterly EPS acceleration ≥ 25%.

partialRule check says AVOID (3/8 checks passed) — CANSLIM read: fails C: Quarterly EPS acceleration ≥ 25%.

Passing evidence
L: RS rank ≥ 80 (IBD leadership)RS rank 82
N: Near 52-week high or RS line new high1.1% below high | RS line new high: False
Failing evidence
C: Quarterly EPS acceleration ≥ 25%-432.5% QoQ
A: Annual earnings & revenue qualityRev +2.4% | ROE -16.3%
3/8 checks
Method → Playbook → Ask →
Weinstein Watch C Stage-analysis read: Stage 2 is present; 2 supporting checks need improvement.

mediumClassic Stage 2 advancing phase — strong weekly trend confirms uptrend. This is Weinstein's sweet spot: buy and hold while price remains above the 30-week MA.

Passing evidence
Stage 2 (Advancing phase) confirmedStage 2 (Advancing)
Price above 30-week MA (200-day proxy)Price $158.69 vs MA200 $139.06
Failing evidence
Volume expansion above averageVolume ratio 1.05x
Weekly price coiling (Stage 2 consolidation)Tightening weekly range confirms base
5/7 checks
Method → Playbook → Ask →
dennis Watch C Turtle read: no breakout yet. Price is pressing the 20-day high. The system waits for the print; it never anticipates.
Passing evidence
No breakdown below the 20-day channel20-day low $142.60
Volatility-unit sizing (1N ≈ 1% of equity)1N = $3.77 (2.38% of price); the Turtles size 1 unit so a 1N move ≈ 1% of equity, making the 2N stop ≈ 2% equity risk
Failing evidence
S1: 20-day Donchian breakoutNot confirmed
S2: 55-day Donchian breakoutNot confirmed
5/8 checks
Method → Playbook → Ask →
zanger Watch B Zanger read: the structure is fine but the breakout quality is not there yet — wait for 150%+ volume on the break.

mediumZanger would buy the Cup & Handle breakout only with 150-200% volume, never more than 5% above the breakout point, with a 2-3% stop set at entry. His edge over O'Neil is the exit plan: sell 20-30% of the position at +15-20%, then trail the rest on the 10/20-day moving average.

Passing evidence
Named Zanger pattern onlyCup & Handle
Not extended (≤5% above the breakout point)Measured as passing
Failing evidence
Breakout volume 1.5-2.0x averageNot confirmed
5/6 checks
Method → Playbook → Ask →
zweig Watch D Zweig read: part of his screen passes but not all: EPS growth above the market (≥15% QoQ); Insider buying — wait for the full growth screen before treating this as a Zweig setup.
Passing evidence
Reasonable price for the growth (P/E ≤ 35)Trailing P/E 23.4x — no PEG or forward P/E stored
Price strength (RS ≥ 70)RS score 82 — Zweig buys strength, not bargains
Failing evidence
EPS growth above the market (≥15% QoQ)-432.5% QoQ — Zweig wants growth above the S&P average
Insider buyingNo insider buying flagged
3/8 checks
Method → Playbook → Ask →
Livermore Watch B Pivotal-point read: constructive evidence is present, but volume vs average is unresolved.
Passing evidence
Price$158.69
Relative strengthRS 82
Failing evidence
Volume vs average1.05x
Pivotal point cleared on expanding volumeNot confirmed
4/6 checks
Method → Playbook → Ask →
Darvas Watch B Box-theory read: constructive evidence is present, but volume vs average is unresolved.

mediumStock is at the top of its box — Darvas would wait for a decisive breakout on volume.

Passing evidence
Price$158.69
Relative strengthRS 82
Failing evidence
Volume vs average1.05x
Box top broken on heavy volumeNot confirmed
4/6 checks
Method → Playbook → Ask →
Wyckoff Watch B Supply-and-demand read: constructive evidence is present, but volume vs average is unresolved.
Passing evidence
Price$158.69
Relative strengthRS 82
Failing evidence
Volume vs average1.05x
Sign of Strength confirmed on expanding volume1.05x average volume — needs ≥1.4x
4/6 checks
Method → Playbook → Ask →
Base & Breakout
Breakout follow-through

No active breakout tracked — Legend AI monitors daily for pivot-point breaks. What's a breakout?

Unlock Base & Breakout Tracking
RS Line vs SPY 52-week relative strength · blue = RS line · dashed = MA50 · dot = NH ▲ Rising
118RS Line (52W)
Accumulation / Distribution last 65 sessions · green = acc on high vol · red = dist on high vol Net +4 E
A: 16 D: 12 Net: +465 sessions
Minervini · Grade Card
Fundamentals & leadership quality — Minervini’s published criteria · 4/7 met
B 4/7 criteria
Separate score from the Minervini Trend Template (7/8): the Trend Template grades the price structure, this grades the company & leadership (earnings, sales, margins, RS rank). A stock can ride a clean trend while its fundamentals lag, so the two often differ by design — they are not the same checklist.
✗ EPS acceleration ≥25% QoQ -433%
✗ Revenue growth ≥20% YoY +2%
✓ Gross margin ≥30% 80%
✗ ROE ≥17% -16%
✓ RS rating ≥80 (leadership) 82
✓ Stage 2 uptrend (Weinstein) Stage 2
✓ Within 25% of 52W high -1.1%

Method Playbook

Trade it like Wyckoff EXACT LEVELS · PRO
Wyckoff B · Watch — The deterministic methodology check is Watch; wait for the failing or incomplete criteria to improve before the trigger can qualify.
Pivot
Pro level
Published-method rule: Use the Spring/test, Sign of Strength, creek, or Last Point of Support boundary identified by the active structure.
Evidence: Canonical setup geometry is available with Pro.
Entry trigger
Pro level
Published-method rule: Require a completed test or Sign of Strength/Last Point of Support confirmation with improving demand versus supply.
Evidence: Canonical setup geometry is available with Pro.
Initial stop
Pro level
Published-method rule: Start below the Spring/test low or structural support whose failure would invalidate the accumulation read.
Evidence: Canonical setup geometry is available with Pro.
Trail
Rule-based
Published-method rule: Raise protection beneath successive Last Points of Support or meaningful higher lows during markup; never loosen it.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.
Exit / invalidation
Pro level
Published-method rule: Exit on a failed Sign of Strength, support loss, or clear supply-dominant reversal such as an upthrust failure.
Evidence: Canonical setup geometry is available with Pro.
Deterministic educational plan, not a recommendation. No order or stop is changed automatically. Method and sources →

Pattern Analysis

Cup & Handle Historical replay: +20% before −8% within 40 sessions: 16% (n=376) · source bars 2024-11-01–2026-10-26 · avg +0.3% per setup (+0.03R) ⚠ Volatility widening into breakout ⚠ Bearish RSI divergence
70 setup score
RS Score 82
Trend template 7/8
CANSLIM 66.1* (B)
22.1% cup depth 6.6% handle 8 sessions since breakout
  • Cup 22.1% deep from a $155.73 left rim to a $121.39 low
  • Rims 1.0% apart (ideal, within 10%)
  • Handle pulled back 6.6% over 5 bars from $152.62 to $142.60
  • Handle sits in the upper half of the cup
  • Rounded U-shaped bottom
  • Pivot $154.20 fixed at the handle high
  • Breakout: 8 bars since the first close above the pivot
  • Volume dried up in the handle
Raw detector evidence · confidence is a heuristic match score, not a probability depth=22.1%, handle_pb=6.6%, lips_diff=1.0%, upper_half=yes, u_shape=yes, near_pivot=yes, orderly=yes | Strong trend (7/8) | Top RS (82) | High-confidence pattern (97%) | Power Trend | Stage 2 | Readiness 77/100 (watch) | CANSLIM 66.1 (B) | ⚠ Volatility widening into breakout; Bearish RSI divergence setup_key=cup_handle|2026-06-10|2026-09-23|154.20 · cup_handle/2026-10-03 anchors={"bottom": {"bar": 114, "bars_ago": 95, "date": "2026-06-10", "price": 121.39}, "breakout": {"bar": 202, "bars_ago": 7, "date": "2026-10-15", "price": 157.37}, "handle_high": {"bar": 190, "bars_ago": 19, "date": "2026-09-29", "price": 152.62}, "handle_low": {"bar": 195, "bars_ago": 14, "date": "2026-10-06", "price": 142.6}, "left_lip": {"bar": 33, "bars_ago": 176, "date": "2026-02-12", "price": 155.735}, "right_lip": {"bar": 186, "bars_ago": 23, "date": "2026-09-23", "price": 154.2}}
Why This Setup? D+W Confluence
cup handle Cup & Handle · schematic

depth=22.1%, handle_pb=6.6%, lips_diff=1.0%, upper_half=yes, u_shape=yes, near_pivot=yes, orderly=yes | Strong trend (7/8) | Top RS (82) | High-confidence pattern (97%) | Power Trend | Stage 2 | Readiness 77/100 (watch) | CANSLIM 66.1 (B) | ⚠ Volatility widening into breakout; Bearish RSI divergence

Ask a Legend ▾
Darvas Box ⚠ Volatility widening into breakout ⚠ Bearish RSI divergence
70 setup score
RS Score 82
Trend template 7/8
CANSLIM 65.1* (B)
box top: 160.51 box bottom: 151.71 box height pct: 0.058 vol ratio: 1.047 is breakout: ✗ pct from 52w high: 0.0 validation reason: valid generic setup multi tf evaluated: ✓ multi tf reason: weekly: within 15% of 52-week high (Darvas box territory)
Why This Setup? D+W Confluence
Darvas Box · schematic

Box: top=160.51, bottom=151.71, height=5.8%, breakout=no, vol_ratio=1.0x, 0% from 52w high | Strong trend (7/8) | Top RS (82) | High-confidence pattern (80%) | Power Trend | Stage 2 | Readiness 72/100 (watch) | CANSLIM 65.1 (B) | ⚠ Volatility widening into breakout; Bearish RSI divergence

Ask a Legend ▾
The Universal Edge Check · context only

What the setup still has going for it, recorded for later. The verdict above stands — these principles do not overrule it.

4/7 universals met
  • Clear of earnings — not met in 1 days — event risk
  • A relative-strength leader — partly met RS rank 63 — middling
  • Volume confirms — partly met 1.1× average — light
  • Asymmetric reward — met Met — levels are a Pro detail
  • In a confirmed uptrend — met Stage 2 · Trend template 7/8
  • Not chasing (in range) — met Met — levels are a Pro detail
  • Risk is defined — met Met — levels are a Pro detail
Why these seven? → The Universal Edge

Minervini Trend Template

7/8

Grades the price structure — moving-average stacking, distance from the 52-week high/low, and relative strength above the ≥70 uptrend bar. This is the technical trend check; the company's fundamentals and ≥80 RS leadership are scored separately in the Grade Card.

Price above SMA 150 & 200 $158.69 vs SMA150 $137.99 / SMA200 $139.06
SMA 150 above SMA 200 SMA150 $137.99 vs SMA200 $139.06
SMA 200 trending up Slope +2.90 over 20 days
SMA 50 above SMA 150 & 200 SMA50 $149.25
Price above SMA 50 $158.69 vs SMA50 $149.25
30%+ above 52-week low +39.2% from $114.02
Within 25% of 52-week high -1.1% from $160.51
RS score above 70 RS 82

Fundamentals

52W Range
96%
Mkt Cap SEC
196.8B
EPS QoQ
-433%
Rev YoY
+2%
ROE
-16%
Gross Margin
80%
D/E
1.10
EPS TTM
$6.78
P/E TTM
23.4x
Float
1.2B
Insider
No Buy

Company

Company profile
Gilead Sciences, Inc.
GILD · NASDAQ · Health Technology · Biotechnology
Track all markets on TradingView
O'Neil · Grade Card
CANSLIM — current EPS, annual EPS, new highs, supply, leader RS, inst. sponsorship, market
B 66.1* CANSLIM * disqualified on C, M
C · Curr. EPS
20
A · Annual EPS
45
N · New Highs
100
S · Supply/Demand
70
L · Leader RS
82
I · Inst. Spons.
96
M · Market
30

Weekly Context

Multi-timeframe signals from weekly bars
W. Trend
7/8
W. RS
78
W. Support
$121.39
W. Resist
$160.51
W. Patterns
Cup & Handle Base Breakout
Weekly Structure

Scan History

20× streak
Oct 23: 70 (Cup & Handle)Oct 26: 70 (Cup & Handle)Oct 27: 70 (Cup & Handle)70
Oct 27
Cup & Handle ✓ Gate
70
Oct 26
Cup & Handle ✓ Gate
70 0.0%
Oct 23
Cup & Handle ✓ Gate
70 +1.7%

Latest News

Headlines for GILD
Loading headlines…

Get the full picture on GILD

Pro members see entry/stop/target levels, R:R ratios, intraday alerts, and every setup detected across 500+ symbols daily.

Start 7-Day Free Trial